Dr Nicole Ann Cavenagh, PHD | |
3211 E Warm Springs Rd, Las Vegas, NV 89120-3157 | |
(702) 912-5848 | |
(702) 912-0442 |
Full Name | Dr Nicole Ann Cavenagh |
---|---|
Gender | Female |
Speciality | Clinical Neuropsychologist |
Location | 3211 E Warm Springs Rd, Las Vegas, Nevada |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1326373960 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
103TB0200X | Psychologist - Cognitive & Behavioral | P40584 (Nevada) | Secondary |
103G00000X | Clinical Neuropsychologist | PY0584 (Nevada) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr Nicole Ann Cavenagh, PHD 3211 E Warm Springs Rd, Las Vegas, NV 89120-3157 Ph: (702) 912-5848 | Dr Nicole Ann Cavenagh, PHD 3211 E Warm Springs Rd, Las Vegas, NV 89120-3157 Ph: (702) 912-5848 |
News Archive
Jiangbo Pharmaceuticals, Inc., a pharmaceutical company with its principal operations in the People's Republic of China, today announced financial results for its fourth quarter and fiscal year ended June 30, 2010. The Company's annual report on Form 10-K has been filed with the U.S. Securities and Exchange Commission and is available on the Company's website.
A case report titled, "Acute Solar Retinopathy Imaged With Adaptive Optics, Optical Coherence Tomography Angiography, and En Face Optical Coherence Tomography", appeared in the journal JAMA Ophthalmology, where the authors describe the damage caused by the sun's rays to the eyes of a woman who viewed the recent solar eclipse without adequate eye protection. This type of eye damage is termed acute solar retinopathy.
For men with "low-risk" prostate cancer initially managed with active surveillance, cancer-related factors such as tumor grade and size are key risk factors for conversion to active treatment, reports a study in The Journal of Urology®, an Official Journal of the American Urological Association.
Researchers performed a cross-sectional study in the city of Bangui, the capital of the Central African Republic from July 12, 2021, to August 20, 2021.
The human leucocyte antigen-C and killer immunoglobin-like receptor genotypes are associated with response to interferon-based therapy in patients with chronic hepatitis B virus infection positive for hepatitis B e antigen, say researchers.
› Verified 3 days ago